ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

RVNC Revance Therapeutics Inc

2.845
0.045 (1.61%)
最終更新日: 03:06:57
15分遅延
名称 銘柄コード 市場 種別
Revance Therapeutics Inc RVNC NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.045 1.61% 2.845 03:06:57
始値 安値 高値 終値 前日終値
2.81 2.745 2.87 2.80
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/6/1505:05BWRevance Reports Inducement Grants Under Nasdaq Listing Rule..
2024/5/2905:05BWRevance to Participate in Upcoming Investor Conferences
2024/5/1005:33EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/1005:08EDGAR2Form 8-K - Current report
2024/5/1005:06BWRevance Reports First Quarter 2024 Financial Results,..
2024/5/1005:05BWRevance Expands into the U.S. Therapeutics Market with the..
2024/5/0305:05BWRevance to Release First Quarter 2024 Financial Results on..
2024/4/1221:00BWRevance to Present New DAXXIFY® Data at the American Academy..
2024/3/2805:05BWRevance Reports Inducement Grants Under Nasdaq Listing Rule..
2024/3/0906:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0607:08EDGAR2Form 8-K - Current report
2024/3/0607:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/3/0507:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0507:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0506:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0506:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0423:25BWRevance Announces Pricing of $100.0 Million Public Offering..
2024/3/0420:39EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/3/0420:37BWRevance Announces Proposed Public Offering of Common Stock
2024/3/0106:36EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/2/2906:07EDGAR2Form 8-K - Current report
2024/2/2906:05BWRevance Reports Fourth Quarter and Full Year 2023 Financial..
2024/2/2122:01BWRevance to Release Fourth Quarter and Full Year 2023..
2024/2/2122:00BWRevance to Participate in Upcoming Investor Conferences
2024/2/1505:45EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1406:28EDGAR2Form 8-K - Current report
2024/2/1323:39EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0706:04EDGAR2Form 8-K - Current report
2024/2/0306:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0306:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0306:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0222:00BWRevance Receives Permanent J-Code for DAXXIFY® and Announces..
2024/2/0122:00BWRevance to Participate in the Guggenheim 6th Annual..
2024/1/1120:18IHMARKETNEWSWall Street Highlights: Mastercard’s Financial Rise,..
2024/1/0822:01EDGAR2Form 8-K - Current report
2024/1/0822:00BWRevance Provides Corporate Update, Preliminary Fourth..
2024/1/0406:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0406:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0406:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1906:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1606:04EDGAR2Form 8-K - Current report
2023/12/1219:50IHMARKETNEWSHasbro Job Cuts, Oracle’s Stock Decline, Google’s Epic..
2023/11/1506:22EDGAR2Form S-3ASR - Automatic shelf registration statement of..
2023/11/0906:33EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0906:09EDGAR2Form 8-K - Current report
2023/11/0906:06BWRevance Reports Third Quarter 2023 Financial Results,..
2023/11/0906:05BWRevance Appoints Erica Jordan as Chief Commercial Officer,..
2023/11/0622:00BWRevance to Participate in Upcoming Investor Conferences
2023/11/0121:00BWRevance to Release Third Quarter 2023 Financial Results on..
2023/10/2621:00BWDAXXIFY® Becomes First Facial Injectable to be Named to..

最近閲覧した銘柄

Delayed Upgrade Clock